搜索临床试验以:Peginterferon alfa ribavirin
总计3508个结果
-
Coordinación de Investigación en Salud, MexicoUniversity of Guadalajara; Instituto Mexicano del Seguro Social完全的
-
Hoffmann-La Roche完全的
-
Southwest Oncology GroupNational Cancer Institute (NCI); Cancer and Leukemia Group B完全的
-
Genzyme, a Sanofi Company完全的
-
Merck KGaA, Darmstadt, GermanyMerck, S.L., Spain终止
-
National Cancer Institute (NCI)完全的
-
DUSA Pharmaceuticals, Inc.撤销
-
National University of MalaysiaSanten Pharmaceutical Co., Ltd.未知
-
Augusta UniversityYale University; University of Alabama at Birmingham; Tufts University未知
-
Masonic Cancer Center, University of Minnesota终止
-
GeneScience Pharmaceuticals Co., Ltd.The First Affiliated Hospital with Nanjing Medical University; The First Affiliated Hospital... 和其他合作者未知
-
National Cancer Institute (NCI)终止乳腺癌 | 转移性乳腺癌 | 三阴性乳腺癌 | 激素受体阴性乳腺癌 | HER2+ 乳腺癌美国
-
FHI 360University of Washington; University of North Carolina, Chapel Hill; World Health Organization; Kenya... 和其他合作者完全的
-
Benaroya Research InstituteSanofi完全的
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的IIIB 期肝细胞癌 AJCC v7 | IIIC 期肝细胞癌 AJCC v7 | BCLC B 期肝细胞癌 | BCLC C期肝细胞癌 | 丙型肝炎感染 | IV 期肝细胞癌 AJCC v7 | III 期肝细胞癌 AJCC v7 | IIIA 期肝细胞癌 AJCC v7 | IVA 期肝细胞癌 AJCC v7 | IVB 期肝细胞癌 AJCC v7 | 难治性肝癌美国
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); Cancer and Leukemia Group B; SWOG Cancer Research Network完全的
-
National Institute of Allergy and Infectious Diseases...完全的
-
Merck Sharp & Dohme LLC终止膀胱过度活动症 | 膀胱过度活动症
-
National Cancer Institute (NCI)完全的复发性甲状腺癌 | IVA 期滤泡性甲状腺癌 | IVA 期甲状腺乳头状癌 | IVB 期滤泡性甲状腺癌 | IVB 期乳头状甲状腺癌 | IVC 期滤泡性甲状腺癌 | IVC 期甲状腺乳头状癌美国
-
Ferris State UniversityRetina Specialists of Michigan终止
-
Southwest Oncology GroupNational Cancer Institute (NCI)完全的难治性浆细胞骨髓瘤 | 复发性浆细胞骨髓瘤美国
-
University of FloridaPatient-Centered Outcomes Research Institute; Merck Sharp & Dohme LLC; AbbVie完全的
-
Joint Authority for Päijät-Häme Social and Health...完全的
-
Stanford UniversityMerck Sharp & Dohme LLC暂停
-
Oncoimmune, Inc., a subsidiary of Merck & Co.,...National Cancer Institute (NCI); University of Michigan Rogel Cancer Center; Ohio State University 和其他合作者完全的Efprezimod Alfa (CD24Fc, MK-7110) 用于预防清髓性同种异体造血干细胞移植 (HSCT) 后急性移植物抗宿主病 (GVHD) 的 II 期试验 (MK-7110-002)白血病 | 造血干细胞移植 | 移植物抗宿主病美国
-
Masonic Cancer Center, University of Minnesota终止
-
Alisyn FacemireORA, Inc.完全的